Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07449234
Eligibility Criteria:
Inclusion criteria:
* Must have a confirmed diagnosis of moderate-to-severe plaque psoriasis requiring systemic treatment
* Participants who are currently treated with Ustekinumab (either the originator or its biosimilar) and who are medically indicated to switch to Guselkumab
* Participants who, based on the Investigator's decision, should initiate treatment with Guselkumab
* Participants must understand and be willing and able to answer patient-reported outcomes (PROs)
* Must sign an informed consent form (ICF) allowing data collection and source data verification in accordance with local requirements
Exclusion criteria:
* Contraindication or hypersensitivity to Guselkumab or any ingredient in the injection solution/liquid
* Pregnancy or breastfeeding
* Currently enrolled in an interventional study
* Currently enrolled in an observational study sponsored or managed by a Janssen company
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07449234
Study Brief:
Protocol Section:
NCT07449234